HYADD-4 Hydrogel

non-crosslinked hyaluronic acid alkylamide · Fidia Farmaceutici s.p.a.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HYADD-4 Hydrogel, covering 2015-10-05 to 2015-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee [NA]

See pricing